RxDoctor Payments Data

Shirley Frimpong

Adult Health · Frederick, MDNPI 1508162306

Payments from drug & device makers

$1,243in general payments, 2019–2025

Across 65 payments — averaging $19.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$350
  • Scilex Pharmaceuticals Inc.$167
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$125
  • Galderma Laboratories, L.p.$112
  • Medtronic$92
  • Biodelivery Sciences International, Inc.$65
  • plus $331 from 10 others

What the payments were for

  • Food & beverage$1,243100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,243 in reported general payments places this provider in the 70th percentile of 542 adult health providers in Maryland.

See all adult health providers in Maryland

Medicare billing

Part B allowed, 2024
$124,124
Medicare patients
407
Services billed
1,213

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl28$22,183
OxycontinOxycodone Hcl30$10,667
Xtampza ErOxycodone Myristate19$9,784
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen289$8,676
Oxycodone Hcl489$8,479
MovantikNaloxegol Oxalate15$6,932
ZtlidoLidocaine14$5,495
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl22$5,314
Buprenorphine11$3,714
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen141$3,714
Morphine Sulfate ErMorphine Sulfate100$3,690
Pregabalin146$3,689
Gabapentin231$2,646
Lidocaine30$2,371
Fentanyl22$1,922

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er$350$31,96847 claims
Redhill Biopharma Inc.Movantik$58$6,93215 claims
Scilex Pharmaceuticals Inc.Ztlido$167$5,49514 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 542 adult health providers in Maryland.

Other adult health in Frederick

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →